- Home
- HALO vs AXS Comparison
HALO vs AXS Comparison
Compare HALO & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HALO | AXS |
|---|---|---|
| Founded | 1998 | 2001 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HALO | AXS |
|---|---|---|
| Price | $68.36 | $109.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $73.33 | ★ $117.00 |
| AVG Volume (30 Days) | ★ 2.6M | 646.3K |
| Earning Date | 11-03-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | 56.68 | ★ 68.27 |
| EPS | 4.74 | ★ 12.10 |
| Revenue | $1,242,852,000.00 | ★ $6,301,015,000.00 |
| Revenue This Year | $34.83 | $6.62 |
| Revenue Next Year | $24.84 | $8.64 |
| P/E Ratio | $14.39 | ★ $9.00 |
| Revenue Growth | ★ 31.19 | 5.59 |
| 52 Week Low | $46.26 | $83.90 |
| 52 Week High | $79.50 | $109.23 |
Technical Indicators
Market Signals| Indicator | HALO | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 58.01 | 76.24 |
| Support Level | $61.23 | $105.67 |
| Resistance Level | $69.28 | $108.12 |
| Average True Range (ATR) | 1.98 | 1.87 |
| MACD | 0.62 | 0.64 |
| Stochastic Oscillator | 91.06 | 94.92 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.